Objective. To explore the association of non-organ-specific autoimmune responses against three distinct Ro antigen-related reactivities (Ro52, Ro60, p57) with a history of pregnancy loss in women with autoimmune disorders.
Among the multiple factors implicated in the pathogen-(p57) were recently proposed as an additional risk factor esis of adverse pregnancy outcome, autoimmune disin the pathogenesis of neonatal lupus syndrome. These orders appear to play a prominent role [1] [2] [3] . Antiantibodies are found in 10% of SLE patients, always in Ro/SSA antibody (the main causative factor of congenassociation with anti-Ro/SSA antibodies [9] . The extent ital heart block) has been considered recently in the to which antibodies against each of the three peptides pathogenesis of pregnancy loss in women with connectdescribed may interact or contribute independently to ive tissue disorders, including both systemic lupus erythrecurrent pregnancy loss in patients with SLE and other ematosus (SLE) [4] [5] [6] [7] and other autoimmune disorders autoimmune diseases is not known. such as Sjö gren's syndrome (SS ) and rheumatoid arthIn the present work, we evaluated whether reactivity ritis (RA) [7] . It is well known that anti-Ro/SSAagainst each of the three determined antigenic specificitpositive sera may contain either of two sets of antibodies ies is independently associated with the risk of recurrent recognizing either a 60 kDa (Ro60) or a 52 kDa (Ro52) pregnancy loss in women with a variety of autoimmune polypeptidic component of the Ro molecule [8] .
disorders, and whether these associations may be conMoreover, IgG antibodies against a 57 kDa protein founded by other potentially important autoimmune risk factors, in particular the presence of antithyroid antibodies, often detected in these patients [10, 11] . To study of 70 women known to have anti-Ro/SSA were reported to have neonatal lupus, but information was not collected systematically. responses. Furthermore, in order to evaluate better Since in our previous study [7] possible confounders whether the association of the above responses was (presence of anti-La/SSB, anti-DNA or anticardiolipin independent of other autoimmunity risk factors which in the serum, age at anti-Ro/SSA diagnosis, number of have been linked to recurrent pregnancy loss, such as pregnancies, indicator whether outcome occurred before antithyroid antibodies [12] [13] [14] and antiphospholipid or after diagnosis) did not affect the risk of recurrent antibodies [15-17], we performed a case-control study pregnancy loss, it was not considered necessary to study including 40 Ro/SSA-positive women and 40 ageand analyse the same parameters in the present report. matched Ro/SSA-negative women with autoimmune
We nevertheless considered the presence of anticardiolidisorders. This design allowed us to evaluate how the pin antibodies as an adjusting factor in the multivariate composite profile of anti-Ro/SSA non-organ-specific analyses, since this has been proposed to be strongly responses and organ-specific autoimmune responses related to pregnancy loss in other studies [15] [16] [17] . The (such as those against thyroid antigens) correlate with effect of anticardiolipin antibodies was not significant pregnancy loss.
in our study and it did not affect the magnitude of the observed associations, therefore it is not reported.
Materials and methods

Laboratory methods
Counterimmunoelectrophoresis. Antibodies to Ro/SSA Patients antigen were assayed by CIE using calf thymus extract as an antigen source, as described by Bunn et al. [23] . In the retrospective cohort study, serum samples from Precipitin lines formed were stained with Coomassie 70 women with various autoimmune rheumatic disorders brilliant blue R and antibody specificity was determined were selected on the basis of anti-Ro/SSA antibody in by direct comparison with reference sera. serum as determined by counterimmunoelectrophoresis
Western blot with HeLa cell extract. Cytoplasmic (CIE) during routine evaluation in the Laboratory extract was prepared from cultured HeLa cells as of Immunology, Department of Pathophysiology, described previously. Samples of cytoplasmic HeLa University of Athens, from January 1995 to January extracts corresponding to 40 × 106 cells were loaded 1996. All participants had a history of at least one onto 15% acrylamide, 0.085% bisacrylamide gels. In pregnancy. All these sera were tested by Western blotting order to facilitate the electrophoretic separation of the for the detection of reactivities against the 60, 52 and 52 kDa Ro/SSA antigen from the 48 kDa La/SSB anti-57 kDa proteins. In addition, information on antinuclear gen, the final ratio of acrylamide to bisacrylamide was antibodies (ANA) (detected by indirect immunofluores-172.4. Sodium dodecyl sulphate (SDS)-polyacrylamide cence using Hep2 epithelial cells as substrate, positive gel electrophoresis, electrophoretic transfer and immu-ANA titre 1/80) and on other precipitin antibodies was noblotting were subsequently performed as described also recorded. These patients had been evaluated at the previously [24, 25] . out-patient rheumatology clinic in the Department of Radioimmunoassays for the detection of antithyroid Pathophysiology, University of Athens, and included antibodies. Thyroid peroxidase antibodies and thyroglo-30 patients with SLE, 26 with SS, four with systemic bulin antibodies were assayed with radioimmunoassay sclerosis (SScl ), three with RA and seven with an kits (DYNO testB). The TPO assay is a single-antibody undifferentiated connective tissue disorder. All diagnoses radioimmunoassay in which endogenous thyroid peroxiwere based on previously established criteria [18] [19] [20] [21] .
dase antibody is reacted with enzymatic active native In the case-control study, 40 of the above anti-TPO from human thyroids. During incubation, solidRo/SSA-positive sera and an equal number of agephase monoclonal anti-TPO antibodies and enzymatic matched anti-Ro/SSA-negative sera (based on CIE active native TPO from human thyroids form a complex results) from autoimmune women with a history of at with another iodine-125-labelled monoclonal anti-TPO least one pregnancy were tested for the presence of antibody. Reaction tubes are then centrifuged to separthyroid peroxidase (TPO) antibodies and thyroglobulin ate tracer bound to antibody from the non-reacted, free antibodies by a competitive radioimmunoassay [22] . portion in the supernatant, which is decanted. The Serum aliquots from patients and controls were stored radioactivity bound in the pellet is directly proportional at −20°C until assayed.
to the concentration of TPO antibody present in the Data regarding the obstetric history of all study serum. Thyroglobulin antibody is detected in a system participants were extracted from a previous study identical to that described for TPO antibody, except investigating the association of anti-Ro/SSA with recurthat iodinated thyroglobulin is used in place of thyroid rent pregnancy loss [7] . Recurrent pregnancy loss was perodixase. A positive result in TPO and thyroglobulin defined as the incidence of at least two stillbirths or antibodies was defined as >60 and >50 IU/ml, spontaneous abortions of first or second trimester.
respectively. Spontaneous abortion was defined as the spontaneous Statistical methods loss of a fetus before the end of the 22nd week of gestation. Stillbirth was defined as intrauterine fetal Associations of reactivities against Ro52, Ro60, p57 and antithyroid antibodies with recurrent pregnancy losses death occurring after 22 weeks of gestation. No infants were evaluated with logistic regression. Both univariate pregnancy outcomes was 3.4% (1/29), 26.9% (18/67), 33.9% (20/59) and 58.8% (10/17) in pregnancies of and multivariate regressions were performed. Recurrent pregnancy loss was the dependent variable and each women with 0, 1, 2 and 3 peptide reactivities, respectively (P < 0.001). These percentages show a clear gradation patient was used as an observation. A different set of logistic regression models considered each pregnancy as of risk. a separate observation, excluding induced first trimester Case-control study abortions. The dependent variable in these models is the pregnancy outcome ( live born vs stillborn or spontan-
The cases and controls were well matched both for the age at Ro determination [mean 44.7 (.. 12.5) and 44.6 eous abortion). Induced elective abortions of the first trimester were excluded from this analysis, since these (.. 12.0) yr] and age at last pregnancy [mean 29.8 (.. 6.0) and 31.7 (.. 6.0) yr]. Twelve women were classified pregnancies may be considered to be censored (in the large majority, it is unknown whether they would have as having had recurrent pregnancy loss. There were a total of 314 pregnancies, including 115 elective induced resulted in stillbirth, spontaneous abortion or a live birth). Multiple gestations were counted as single events abortions, seven stillbirths, 33 spontaneous abortions of the first trimester, eight spontaneous abortions of the in all analyses.
In addition to considering each of the three reactivities second trimester and 151 pregnancies which resulted in live births. Among the 40 Ro-positive women, six had separately, we also considered a score equal to the number of different reactivities in each patient. The one pregnancy, seven had two, six had three, and 21 had more than three pregnancies. Among the 40 score took values between 0 and 3. The relationship of the score with recurrent pregnancy loss and with adverse Ro-negative women, seven had one pregnancy, eight had two, eight had three, and 17 had more than three pregnancy outcomes was investigated with the x2 test.
Statistical analyses were implemented in Advanced pregnancies. Reactivity against each of the three antigenic peptides SPSS [26 ] . All P values are two-tailed.
was associated both with the risk of a woman having had recurrent pregnancy loss and with the risk of adverse outcome for a specific pregnancy in a woman ( Table 2 ).
Results
The same was true for the presence of antibodies against Retrospective cohort study of Ro/SSA-positive women thyroglobulin, but was less evident for antibodies against thyroid peroxidase. Multivariate regressions suggested A total of 289 pregnancies were recorded in 70 antiRo/SSA-positive women, 13 of whom were classified as that the effects of each of three antigenic responses were independent and their magnitude of effect remained having had recurrent pregnancy loss. The mean age at the time of determination of Ro status was 44.9 yr (.. unchanged in the multivariate models, although the estimates were not formally statistically significant when 11.9) and the mean age at last pregnancy was 30.4 yr (.. 6.3). Of the 289 pregnancies, 117 had been electively all three peptides were considered. When the sum score of peptide reactivities was considered, the odds ratio for interrupted in the first trimester, 123 had resulted in live births, and there were eight stillbirths, 34 first trimester recurrent pregnancy loss and for adverse pregnancy outcome was 3.00 (P = 0.002) and 1.85 (P = 0.002), spontaneous abortions and seven second trimester spontaneous abortions. There were seven women with one respectively, for each additional reactivity. When this was adjusted for the presence of antibodies pregnancy, 14 with two pregnancies, 14 with three pregnancies and 35 with more than three pregnancies. against thyroglobulin, the odds ratio for recurrent pregnancy loss and for adverse pregnancy outcome was 3.35 Reactivity against Ro52, Ro60 and p57 was observed in 35/70, 34/70 and 15/70 sera, respectively, and there (P = 0.002) and 1.90 (P = 0.001), respectively, for each additional peptide reactivity. The odds ratios for antithywas no correlation between the presence of any two reactivities (P > 0.6 for all three pairs). Reactivity roglobulin reactivity in these multivariate models were 5.54 (P = 0.025) and 2.30 (P = 0.024), respectively. The against each of the three antigenic peptides was associated both with the risk of a woman having had recurrent strength of the association with the sum score of Ro52, Ro60 and p57 proteins was stronger than the association pregnancy loss and with the risk of adverse outcome for a specific pregnancy in a woman ( Table 1) . Multivariate with Ro/SSA, as determined by CIE, which was a marginal statistical significance [odds ratios 3.58 regressions suggested that the effects of each of three responses were independent and their magnitude of (P = 0.07) and 2.17 (P = 0.024), respectively, in the two logistic models]. effect remained unchanged in the multivariate models. When the sum score of the three reactivities was consid-
The proportion of women with recurrent pregnancy loss was 6.8% (3/44), 13.6% (3/22), 30% (3/10) and ered, the odds ratio for recurrent pregnancy loss and for adverse pregnancy outcome was 3.70 (P = 0.004) 75% (3/4) in women with 0, 1, 2 and 3 peptide reactivities, respectively (P = 0.002). The proportion of adverse and 2.30 (P = 0.0001), respectively, for each additional antigen reactivity.
pregnancy outcomes was 15.7% (17/108), 25% (11/44), 33.3% (10/30) and 58.8% (10/17) in pregnancies of The proportion of women with recurrent pregnancy loss was 0% (0/14), 15.6% (5/32), 25% (5/20) and 75% women with 0, 1, 2 and 3 peptide reactivities, respectively (P < 0.001). These percentages also show a clear grada-(3/4) in women with 0, 1, 2 and 3 peptide reactivities, respectively (P = 0.005). The proportion of adverse tion of risk, as in the cohort study. aMultivariate models considering all three peptides; the magnitude of effects is not different, when also adjusting for antithyroid antibodies in multivariate analyses. NI, not included in this presented model; for both outcomes, multivariate models using back-elimination of variables according to log-likelihood ratio criteria (with P > 0.10 for variable removal and P < 0.05 for variable entry) selected Ro52 and thyroglobulin antibodies as the most important independent variables. A better fit was achieved when the sum score of Ro peptide responses was considered (instead of each peptide separately) along with antithyroglobulin antibodies (see the text).
three distinct peptides Ro60, Ro52 and the recently Discussion recognized p57 [9] were also considered. Furthermore, Among the possible factors implicated in the pathogenthe possible involvement of antithyroid antibodies was esis of adverse fetal outcome in autoimmune patients, explored. antibodies against Ro/SSA antigens may play a signifiOur results suggest that there is a clear gradation of cant role. These antibodies are strongly associated with risk in the association between recurrent pregnancy loss congenital heart block through transplacental passage and the number of distinct Ro/SSA peptides that are during pregnancy, independent of maternal disease recognized by the sera of autoimmune women. In the activity or classification [27] . However, their presence retrospective cohort study, the rates of recurrent pregin maternal serum does not always lead to fetal disease nancy loss varied from 0% among women whose sera and the presence of reactivities against specific antigenic did not recognize any peptides to 75% when all three peptides may be important in this regard. Indeed, Buyon peptides were recognized. The results of the case-control et al. [28] reported that mothers who have only antistudy were also consistent with this clear gradation of Ro/SSA antibodies in low titres that do not recognize risk. The case-control study further revealed that the either 52 or 60 kDa components on SDS immunoblot association of these proteins with adverse pregnancy appear to be at lower risk for giving birth to a child outcomes was not modified when other autoimmune with neonatal lupus. Furthermore, Dorner et al. [29] parameters such as thyroid and cardiolipin autoantibodsupport the view that the coincidence of anti-52 kDa, ies were considered. In particular, the presence of anti-60 kDa and La/SSB antibodies is strongly associated thyroglobulin antibodies seemed to have an independent with complete congenital heart block.
association with a history of recurrent pregnancy loss. In a previous study [7] based on the hypothesis that Overall, our data suggest that the cumulative number unexplained pregnancy loss in autoimmune patients of autoantibody responses against the non-organmay represent an intrauterine feature of congenital heart specific Ro antigen specificities, and possibly also the block, the role of anti-Ro/SSA in the pathogenesis of organ-specific thyroid antigens, may correlate with a recurrent pregnancy loss was investigated. The heterohistory of recurrent pregnancy loss. geneous involvement of this antibody in different clinical Until recently, recurrent pregnancy loss in women groups revealed in this study urged us to investigate the with autoimmune diseases was almost exclusively associrole of other parameters in the pathogenesis of recurrent ated with antibodies against phospholipids [15] [16] [17] . In pregnancy loss in these patients. Thus, in the present the present study, distinct anti-Ro/SSA patterns and study, the fine specificity patterns of maternal antiantithyroid antibodies, especially against thyroglobulin, seemed to be more strongly associated with a history of Ro/SSA antibodies were analysed and antibodies against immune diseases: a retrospective cohort study. Br pregnancy loss. Our findings should not be interpreted of an underlying immune disturbance leading possibly
